SIPARI®    is    a    directed    music-supported    treatment    approach developed    to    improve    language    and    speech    capabilities    of patients   suffering   from   chronic   aphasia.   SIPARI®   was   developed by   Dr.   Jungblut   and   was   first   tried   and   tested   in   cooperation with   the   Medical   Faculty   of   the   University   of   Witten-Herdecke, Germany. In   a   controlled   group-study   with   patients   suffering   from   chronic non-fluent    aphasia    (average    duration    of    aphasia:    11    years) significant   improvements   of   75%   of   all   patients   were   assessed by   a   standardized   language   procedure,   the   Aachener   Aphasie Test (AAT). In    2010    SIPARI®    was    listed    in    the    Cochrane    Review    “Music therapy       for       acquired       brain       injury”       in       the       category “communication”   as   the   only   evidence-based   method.   ref.:   Bradt   J, Magee   WL,   Dileo   C,   Wheeler   BL,   McGilloway   E.   Music   therapy   for   acquired   brain injury.     Cochrane     Database     of     Systematic     Reviews     2010,     Issue     7.     Art.     No.: CD006787. DOI: 10.1002/14651858. CD006787.pub2. Meanwhile,    a    randomized    controlled    trial    (RCT)    as    well    as further     single     case     studies     substantiate     the     extraordinary efficacy   of   SIPARI®   in   the   treatment   of   severely   impaired   chronic aphasia   patients   and   also   patients   who   additionally   suffer   from apraxia of speech. Music   and   language   consist   of   melodic   and   rhythmic   elements, although   these   basic   components   are   differently   emphasized. Undoubtedly,    the    human    voice    represents    the    most    direct connection   between   music   and   language.   Starting   from   singing towards   intonation   up   to   prosody,   the   human   voice   takes   over   a bridging     function,     which     combines     rhythmic     and     melodic components    in    a    unique    manner    because    transitions    can    be produced   step   by   step.   Therefore,   specifically   targeted   rhythmic- melodic    voice    training    represents    the    starting    point    of    the SIPARI®   method.   Apart   from   the   voice,   further   instruments   are used.    Rhythmic    cognition    trainings,    which    are    performed    on instruments,    vocally    or    in    combination    serve    to    encourage planning       and       sequencing       performance.       Another       basic component   of   this   method   constitutes   joint   instrument   playing on     instruments,     which     can     be     used     without     any     musical experience.     These     communication     trainings     support     social interaction   but   also   promote   cognitive   functions   (e.g.   attention, working memory).

Treatment   objectives   using   SIPARI®   include   improving   linguistic, motor,   and   cognitive   functions   and   thereby   supporting   speech- motor    processes    and    those    speech-systematic    processes    that encourage planning and sequencing performance. The   SIPARI®   treatment   is   offered   as   individual   as   well   as   group therapy. The    duration    of    an    indivual    therapy    session    is    45    minutes.    If required,   home   visits   can   be   arranged.   There   is   no   agreement   to cover    costs    by    health    insurances.    At    the    beginning,    a    SIPARI® diagnostic   examination   is   conducted   in   order   to   make   sure   that this treatment is suitable for the respective patient. In   order   to   intensify   motor   and   cognitive   improvement,   training- CDs     and     DVDs     can     be     purchased     for     home     training     from therapists who successfully completed the SIPARI® training.       Appointments by arrangement If you have further questions, please contact Dr. rer. medic. Monika Jungblut Am Lipkamp 14 Duisburg tel. ++49 203-711319